Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo – Nature Biotechnology
Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229–236 (2020).
Google Scholar
Pacesa, M., Pelea, O. & Jinek, M. Past, present, and future of CRISPR genome editing technologies. Cell 187, 1076–1100 (2024).
Google Scholar
Zhong, G. et al. A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo. Nat. Biotechnol. 38, 169–175 (2020).
Google Scholar
Monteys, A. M. et al. Regulated control of gene therapies by drug-induced splicing. Nature 596, 291–295 (2021).
Google Scholar
Liu, R. et al. Optogenetic control of RNA function and metabolism using engineered light-switchable RNA-binding proteins. Nat. Biotechnol. 40, 779–786 (2022).
Google Scholar
Pfeiffer, L. S. & Stafforst, T. Precision RNA base editing with engineered and endogenous effectors. Nat. Biotechnol. 41, 1526–1542 (2023).
Google Scholar
Booth, B. J. et al. RNA editing: expanding the potential of RNA therapeutics. Mol. Ther. 31, 1533–1549 (2023).
Google Scholar
Song, J., Zhuang, Y. & Yi, C. Programmable RNA base editing via targeted modifications. Nat. Chem. Biol. 20, 277–290 (2024).
Google Scholar
Merkle, T. et al. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat. Biotechnol. 37, 133–138 (2019).
Google Scholar
Qu, L. et al. Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs. Nat. Biotechnol. 37, 1059–1069 (2019).
Google Scholar
Reautschnig, P. et al. CLUSTER guide RNAs enable precise and efficient RNA editing with endogenous ADAR enzymes in vivo. Nat. Biotechnol. 40, 759–768 (2022).
Google Scholar
Katrekar, D. et al. Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. Nat. Biotechnol. 40, 938–945 (2022).
Google Scholar
Vogel, P. et al. Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs. Nat. Methods 15, 535–538 (2018).
Google Scholar
Montiel-Gonzalez, M. F., Vallecillo-Viejo, I., Yudowski, G. A. & Rosenthal, J. J. C. Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc. Natl Acad. Sci. USA 110, 18285–18290 (2013).
Google Scholar
Han, W. et al. Programmable RNA base editing with a single gRNA-free enzyme. Nucleic Acids Res. 50, 9580–9595 (2022).
Google Scholar
Cox, D. B. T. et al. RNA editing with CRISPR-Cas13. Science 358, 1019–1027 (2017).
Google Scholar
Kannan, S. et al. Compact RNA editors with small Cas13 proteins. Nat. Biotechnol. 40, 194–197 (2022).
Google Scholar
Xu, C. et al. Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes. Nat. Methods 18, 499–506 (2021).
Google Scholar
Rauch, S. et al. Programmable RNA-guided RNA effector proteins built from human parts. Cell 178, 122–134.e12 (2019).
Google Scholar
Rauch, S., Jones, K. A. & Dickinson, B. C. Small molecule-inducible RNA-targeting systems for temporal control of RNA regulation. ACS Cent. Sci. 6, 1987–1996 (2020).
Google Scholar
Stroppel, A. S., Lappalainen, R. & Stafforst, T. Controlling site-directed RNA editing by chemically induced dimerization. Chemistry 27, 12300–12304 (2021).
Google Scholar
Zhang, Y. et al. Light-triggered site-directed RNA editing by endogenous ADAR1 with photolabile guide RNA. Cell Chem. Biol. 30, 672–682.e5 (2023).
Google Scholar
Hanswillemenke, A., Kuzdere, T., Vogel, P., Jékely, G. & Stafforst, T. Site-directed RNA editing in vivo can be triggered by the light-driven assembly of an artificial riboprotein. J. Am. Chem. Soc. 137, 15875–15881 (2015).
Google Scholar
Bennett, C. F., Baker, B. F., Pham, N., Swayze, E. & Geary, R. S. Pharmacology of antisense drugs. Annu. Rev. Pharmacol. Toxicol. 57, 81–105 (2017).
Google Scholar
Yu, J. et al. Programmable RNA base editing with photoactivatable CRISPR-Cas13. Nat. Commun. 15, 673 (2024).
Google Scholar
Kawano, F., Suzuki, H., Furuya, A. & Sato, M. Engineered pairs of distinct photoswitches for optogenetic control of cellular proteins. Nat. Commun. 6, 6256 (2015).
Google Scholar
Katrekar, D. et al. Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificity. Elife 11, 1–19 (2022).
Google Scholar
Wong, S. K., Sato, S. & Lazinski, D. W. Substrate recognition by ADAR1 and ADAR2. RNA 7, 846–858 (2001).
Google Scholar
Konermann, S. et al. Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell 173, 665–676.e14 (2018).
Google Scholar
Paulmurugan, R. & Gambhir, S. S. Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system for studying protein–protein interactions. Anal. Chem. 79, 2346–2353 (2007).
Google Scholar
Li, H. et al. Efficient photoactivatable Dre recombinase for cell type-specific spatiotemporal control of genome engineering in the mouse. Proc. Natl Acad. Sci. USA 117, 33426–33435 (2020).
Google Scholar
Li, H. et al. Stable transgenic mouse strain with enhanced photoactivatable Cre recombinase for spatiotemporal genome manipulation. Adv. Sci. 9, 1–12 (2022).
Google Scholar
Kuttan, A. & Bass, B. L. Mechanistic insights into editing-site specificity of ADARs. Proc. Natl Acad. Sci. USA 109, E3295–E3304 (2012).
Google Scholar
Wang, X. et al. Develop a compact RNA base editor by fusing ADAR with engineered EcCas6e. Adv. Sci. 10, 1–8 (2023).
Benedetti, L. et al. Optimized vivid-derived magnets photodimerizers for subcellular optogenetics in mammalian cells. Elife 9, 1–49 (2020).
Google Scholar
Martins-Dias, P. & Romão, L. Nonsense suppression therapies in human genetic diseases. Cell. Mol. Life Sci. 78, 4677–4701 (2021).
Google Scholar
Luo, N. et al. Near-cognate tRNAs increase the efficiency and precision of pseudouridine-mediated readthrough of premature termination codons. Nat. Biotechnol. 43, 114–123 (2025).
Google Scholar
Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023).
Google Scholar
Yi, Z. et al. Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo. Nat. Biotechnol. 40, 946–955 (2022).
Google Scholar
MacDonald, B. T., Tamai, K. & He, X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9–26 (2009).
Google Scholar
Liu, C. et al. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837–847 (2002).
Google Scholar
Kay, M. A., He, C.-Y. & Chen, Z.-Y. A robust system for production of minicircle DNA vectors. Nat. Biotechnol. 28, 1287–1289 (2010).
Google Scholar
Lamb, Y. N. & Hoy, S. M. Eftrenonacog alfa: a review in haemophilia B. Drugs 83, 807–818 (2023).
Google Scholar
Nathwani, A. C. et al. Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N. Engl. J. Med. 371, 1994–2004 (2014).
Google Scholar
George, L. A. et al. Hemophilia B gene therapy with a high-specific-activity factor IX variant. N. Engl. J. Med. 377, 2215–2227 (2017).
Google Scholar
Kaczmarek, R. & Herzog, R. W. Treatment-induced hemophilic thrombosis? Mol. Ther. 30, 505–506 (2022).
Google Scholar
Simioni, P. et al. X-linked thrombophilia with a mutant factor IX (factor IX Padua). N. Engl. J. Med. 361, 1671–1675 (2009).
Google Scholar
Guan, Y. et al. CRISPR/Cas9‐mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse. EMBO Mol. Med. 8, 477–488 (2016).
Google Scholar
Anadón, C. et al. Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis. Oncogene 35, 4407–4413 (2016).
Google Scholar
Teoh, P. J. et al. Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. Blood 132, 1304–1317 (2018).
Google Scholar
Nguyen, N. T. et al. Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety. Nat. Nanotechnol. 16, 1424–1434 (2021).
Google Scholar
Huang, Z. et al. Engineering light-controllable CAR T cells for cancer immunotherapy. Sci. Adv. 6, 1–14 (2020).
Google Scholar
Bansal, A., Shikha, S. & Zhang, Y. Towards translational optogenetics. Nat. Biomed. Eng. 7, 349–369 (2023).
Google Scholar
Zhou, Y. et al. A small and highly sensitive red/far-red optogenetic switch for applications in mammals. Nat. Biotechnol. 40, 262–272 (2022).
Google Scholar
Kuwasaki, Y. et al. A red light-responsive photoswitch for deep tissue optogenetics. Nat. Biotechnol. 40, 1672–1679 (2022).
Google Scholar
Bonger, K. M., Chen, L., Liu, C. W. & Wandless, T. J. Small-molecule displacement of a cryptic degron causes conditional protein degradation. Nat. Chem. Biol. 7, 531–537 (2011).
Google Scholar
Hwang, G.-H. et al. Web-based design and analysis tools for CRISPR base editing. BMC Bioinformatics 19, 542 (2018).
Google Scholar
Li, H. et al. Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo. NCBI SRA https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1194220 (2025).
Li, H. et al. Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo. NCBI SRA https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1194292 (2025).
Li, H. et al. Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo. NCBI SRA https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1197542 (2025).
Li, H. et al. Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo. NCBI SRA https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1207784 (2025).
Li, H. et al. Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo. NCBI SRA https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1194549 (2025).
Li, H. et al. Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo. NCBI SRA https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1207789 (2025).
